Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?

Amgen and Merck both maintain annually rising quarterly dividend payments, but the article frames their ability to sustain payout growth differently ahead of significant patent expirations. Merck or Amgen's relative portfolio depth is presented as the key determinant of dividend durability through the upcoming loss-of-exclusivity cycle.